Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
7/18/2017
1
1
We will begin momentarily at 2pm ET
Slides available now! Recordings available as an exclusive ACS member benefit.
Contact ACS Webinars ® at [email protected]
www.acs.org/acswebinars
2
Type them into questions box!
“Why am I muted?” Don’t worry. Everyone is muted except the presenter and host. Thank you and enjoy the show.
Contact ACS Webinars ® at [email protected]
Have Questions?
7/18/2017
2
3
Have you discovered the missing element?
Find the many benefits of ACS membership!
http://bit.ly/benefitsACS
4
Benefits of ACS Membership
http://bit.ly/benefitsACS
Chemical & Engineering News (C&EN) The preeminent weekly news source.
NEW! Free Access to ACS Presentations on Demand® ACS Member only access to over 1,000 presentation recordings from recent ACS meetings and select events.
NEW! ACS Career Navigator Your source for leadership development, professional education, career services, and much more.
7/18/2017
3
5
Let’s get Social…post, tweet, and link to ACS Webinars during today’s broadcast!
facebook.com/acswebinars
@acswebinars
Search for “acswebinars” and connect!
6
“Lauren was an excellent, professional, dynamic, energetic, and inspiring presenter. Because of this ACS Webinar, I am anxious and motivated to make some time to delve into improving my LinkedIn profile and content!”
Meg Draeger STEMM Coordinator Chaminade Julienne Catholic High School
Be a featured fan on an upcoming webinar! Write to us @ [email protected]
How has ACS Webinars benefited you?
®
7/18/2017
4
7
youtube.com/acswebinars
Search for “acswebinars” and connect!
8
Learn from the best and brightest minds in chemistry! Hundreds of webinars presented by subject matter experts in the chemical enterprise.
Recordings are available to current ACS members one week after the Live broadcast date. www.acs.org/acswebinars
Broadcasts of ACS Webinars continue to be available to the general public LIVE every Thursday at 2pm ET!
®
www.acs.org/acswebinars
7/18/2017
5
ChemIDP.org
An individual development planning tool for you!
• Know your career options • Develop strategies to strengthen your skills • Map a plan to achieve your career goals
Upcoming ACS Webinars www.acs.org/acswebinars
10
Thursday, August 3, 2017
Discovering Vismodegib in the Fight Against Skin Cancer Co-produced with ACS Industry Member Programs, ACS Committee on Corporation Associates, and C&EN
Dan Sutherlin, Principal Scientist and Director, Discovery Chemistry, Genentech
Mark Jones, Executive External Strategy and Communications Fellow, Dow Chemical
Contact ACS Webinars ® at [email protected]
Thursday, July 27, 2017
Viral Hepatitis: The Search for a Cure Co-produced with ACS Chemistry of Medicinal Chemistry and AAPS
Michael Sofia, Co-founder and Chief Scientific Officer of Arbutus Biopharma
Stephen Mason, Executive Director of Virology at CaroGen Corporation
7/18/2017
6
11
www.cleancompetition.org
12
www.acs.org/acswebinars Slides available now! Recordings are an exclusive ACS member benefit.
This ACS Webinar was co-produced with the Partnership for Clean Competition
“Chemistry of Anti-Doping: Deterring of Performance-Enhancing Drug Use by Athletes”
Larry Bowers President, LDBowers and former
CSO, US Anti-Doping Agency
Jason Schaff
Forensic Chemist,
US Government
7/18/2017
7
Chemistry of Anti-Doping:
Deterring Performance-Enhancing Drug
Use by Athletes
Larry D. Bowers, PhD
13
It works!
There are powerful incentives to dope Lack of trust that others will not dope and thereby
defraud the individual of their legitimate rewards
Concern that anti-doping programs do not catch cheaters
Concern that the sport organization is not committed to eliminating doping
Concern that some countries are not committed to eliminating doping
Huge personal and financial rewards
Immediate gratification versus delayed sanction (time discounting)
“Win at all costs” mentality
Why do athletes dope?
14
7/18/2017
8
Doping is a rational choice
Decision regarding doping behavior is made by
evaluating the rewards versus risks
Doping is
Instrumental
Communal
Requires expertise
15
Compliance and Sanction Threats
Deterrence is based on threat assessment
Certainty of being detected and
sanctioned
Severity of sanction
Timeliness (Celerity) of sanction
Perceptions are more important in
decision making than facts
Perceptual calibration
Perceptual deterrence
Perceptual (experiential) re-calibration
16
7/18/2017
9
Is Random Drug Testing a Threat?
Assume that an individual uses
a drug three times a month.
The detection window for the
drug is two days.
Assume that the drug testing
program tests 5% of the eligible
pool of athletes at random
each month.
How long does it take to detect
this drug user?
17
• 4 months
• 9 months
• 4 years, 9 months
• 9 years, 4 months
• 19 years, 4 months
How long does it take to detect this drug user?
18
Audience Challenge Question ANSWER THE QUESTION ON BLUE SCREEN IN ONE MOMENT
7/18/2017
10
Does testing change behavior?
Zorzoli M, Rossi F. Drug Test Anal 2010; 2: 542-7.
19
How can we influence perceptions?
Perceptual re-calibration – ensure that experience with the system
reinforces the certainty of being caught
Research to improve detection of doping agents
Research to identify new doping agents
Collection of information to guide testing strategies
“Non-analytical” cases
Ambiguity aversion – uncertain situations increase certainty of
detection
No-advance-notice out-of-competition sample collection
Alternative matrices (e.g., dried plasma spots) to cost-effectively increase testing numbers
20
7/18/2017
11
Synthetic anabolic steroid
detection
21
Steroid Metabolism (Phase I)
Reduction of double bond
Reduction or oxidation of hydroxyl/keto group
Reduction or oxidation of hydroxyl/keto group
Aromatization to form estrogens
6β hydroxylation
16α/β-hydroxylation
Testosterone Androsterone
22
7/18/2017
12
Steroid Metabolism (Phase II)
23
• Several days
• Several weeks
• Several months
• Several years
Synthetic anabolic steroids can be detected in urine for how long after administration?
24
Audience Challenge Question ANSWER THE QUESTION ON BLUE SCREEN IN ONE MOMENT
7/18/2017
13
Detection of Urinary Steroids
GC - MS and GC - MS/MS
SPE sample clean-up
-glucuronidase cleavage
Extract free steroids with t-butyl-
methyl ether or pentane
Derivatization with MSTFA/
NH4I/C2H4SH
GC - MS SIM analysis
HPLC - MS/MS
SPE sample clean-up
Optional conjugate cleavage
Extract free steroids
LC – MS/MS analysis
25
Pros & Cons of Derivatization
26
7/18/2017
14
Methandienone (Dianabol) Epi-methandienone
~ 2-3 days
Edlund PO, Bowers LD, Henion, JD. J Chromatogr 1989; 487: 341-56.
??
27
Schänzer W et al. Rapid Commun Mass Spectrom 2006; 20: 2252-8.
~ 6 days ~ 19 days
28
7/18/2017
15
Long-lived Steroid Metabolites
Tetrahydrogestrinone (THG) Tetrahydro-epi-methyltestosterone-3-sulfate
17-epi-stanozolol-N-glucuronide
29
Detection Window for
Stanozolol Glucuronide Conjugates
30
7/18/2017
16
Challenges with long-lived
metabolite analysis
Decreasing limits of detection and identification of long-
lived metabolites allows detection of anabolic steroids for
many months
Re-analysis of samples from past Olympic Games results
in more positive urine samples and medal re-distribution
Detection of pg/mL metabolites in urine raises
interpretive challenges
Residual metabolites versus new use
Inadvertent ingestion of contaminated meat or grain
“Off-label” medical treatment (e.g., clomiphene for male
infertility)
31
Peptide and protein doping
agent detection
32
7/18/2017
17
• True
• False
Peptide hormones (less than 75 L-amino acids) can be detected in urine.
33
Audience Challenge Question ANSWER THE QUESTION ON BLUE SCREEN IN ONE MOMENT
Insulin-like Growth Factor 1
C C
C C
S
R F
G A
E L
V D
D L R
R
L
M
L Q F V C
C Y
E
A
G
P
E
I
L
E
D
V I G T Q P A R R
S S S
A S
K
A
P
K
L
P A
G
T
P
K
N
F Y
F G
R D
Y
G
G
Molecular mass: 7649 Daltons
Blood concentration: 30-400 ng/ml
34
7/18/2017
18
LC-MS/MS Quantification of IGF-1
Interlaboratory (n=5) study of IGF-1 bottom-up method
Working group has developed serum reference
material with a consensus concentration assigned for LC-MS/MS work
Collaborating with the National Institute for Science and Technology (NIST) to develop an ISO traceable serum-based reference material
35
Urinary Analysis of GHRP2
(D-Ala)-(D-β-Nal)-Ala-Trp-(D-Phe)-Lys –NH2
GHRP 2
(D-Ala)-(D-β-Nal)-Ala-NH2
36
7/18/2017
19
Summary and Conclusions
Doping/cheating in sport is a reflection of society and its problems as a whole
Anti-doping policies should be designed to deter the use of performance-enhancing drugs and involve complex interdisciplinary effort
Perceptual deterrence model provides guidance for optimizing programs to achieve behavior change
Research is an important factor in increasing the perceived certainty of detection, which is the primary factor in assessing risk
Anti-doping testing requires a skilled laboratory staff with expertise in analytical science, biochemistry, clinical chemistry, exercise physiology, pharmacology, hematology, and endocrinology
37
38
www.acs.org/acswebinars Slides available now! Recordings are an exclusive ACS member benefit.
This ACS Webinar was co-produced with the Partnership for Clean Competition
“Chemistry of Anti-Doping: Deterring of Performance-Enhancing Drug Use by Athletes”
Larry Bowers President, LDBowers and former
CSO, US Anti-Doping Agency
Jason Schaff
Forensic Chemist,
US Government
7/18/2017
20
39
www.cleancompetition.org
Upcoming ACS Webinars www.acs.org/acswebinars
40
Thursday, August 3, 2017
Discovering Vismodegib in the Fight Against Skin Cancer Co-produced with ACS Industry Member Programs, ACS Committee on Corporation Associates, and C&EN
Dan Sutherlin, Principal Scientist and Director, Discovery Chemistry, Genentech
Mark Jones, Executive External Strategy and Communications Fellow, Dow Chemical
Contact ACS Webinars ® at [email protected]
Thursday, July 27, 2017
Viral Hepatitis: The Search for a Cure Co-produced with ACS Chemistry of Medicinal Chemistry and AAPS
Michael Sofia, Co-founder and Chief Scientific Officer of Arbutus Biopharma
Stephen Mason, Executive Director of Virology at CaroGen Corporation
7/18/2017
21
41
www.acs.org/acswebinars Slides available now! Recordings are an exclusive ACS member benefit.
This ACS Webinar was co-produced with the Partnership for Clean Competition
“Chemistry of Anti-Doping: Deterring of Performance-Enhancing Drug Use by Athletes”
Larry Bowers President, LDBowers and former
CSO, US Anti-Doping Agency
Jason Schaff
Forensic Chemist,
US Government
42
“Lauren was an excellent, professional, dynamic, energetic, and inspiring presenter. Because of this ACS Webinar, I am anxious and motivated to make some time to delve into improving my LinkedIn profile and content!”
Meg Draeger STEMM Coordinator Chaminade Julienne Catholic High School
Be a featured fan on an upcoming webinar! Write to us @ [email protected]
How has ACS Webinars benefited you?
®
7/18/2017
22
43
youtube.com/acswebinars
Search for “acswebinars” and connect!
44
Benefits of ACS Membership
http://bit.ly/benefitsACS
Chemical & Engineering News (C&EN) The preeminent weekly news source.
NEW! Free Access to ACS Presentations on Demand® ACS Member only access to over 1,000 presentation recordings from recent ACS meetings and select events.
NEW! ACS Career Navigator Your source for leadership development, professional education, career services, and much more.
7/18/2017
23
45
ACS Webinars does not endorse any products or services. The views expressed in this presentation are those of the presenter and do not necessarily reflect the views or policies of the American Chemical Society.
®
Contact ACS Webinars ® at [email protected]
Upcoming ACS Webinars www.acs.org/acswebinars
46
Thursday, August 3, 2017
Discovering Vismodegib in the Fight Against Skin Cancer Co-produced with ACS Industry Member Programs, ACS Committee on Corporation Associates, and C&EN
Dan Sutherlin, Principal Scientist and Director, Discovery Chemistry, Genentech
Mark Jones, Executive External Strategy and Communications Fellow, Dow Chemical
Contact ACS Webinars ® at [email protected]
Thursday, July 27, 2017
Viral Hepatitis: The Search for a Cure Co-produced with ACS Chemistry of Medicinal Chemistry and AAPS
Michael Sofia, Co-founder and Chief Scientific Officer of Arbutus Biopharma
Stephen Mason, Executive Director of Virology at CaroGen Corporation